Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Zeltia SA    ZEL   ES0184940817

ZELTIA SA (ZEL)

0
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Zeltia SA
Operates as a biopharmaceutical company

Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology.

It operates through the Biopharmaceuticals and Consumer Chemicals segments.

The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression.

The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products.

The company was founded on August 3, 1939 and is headquartered in Madrid, Spain.
Managers
NameAgeSinceTitle
José Maria Fernández de Sousa-Faro PhD, MBA-1971Chairman & Chief Executive Officer
Maria Luisa de Francia--Chief Financial Officer
Pedro Fernández Puentes-1971Vice Chairman
Santiago Alfredo Fernández Puentes-1990Proprietary External Director
José Antonio de Urquizu Iturrarte, MBA-1991Independent External Director
Jaime Zurita Sáenz de Navarrete, LLD-2007Independent External Director
José Félix Pérez-Orive Carceller, MBA-1990Other External Director
Eduardo Serra Rexach682007Independent External Director
Carlos Solchaga Catalán702010Independent Director
José María Bergareche Busquet-2010Independent External Director
Shareholders
NameShares%
José Maria Fernández de Sousa-Faro, PhD, MBA 14,269,511 6.42%
Mera Sandra Ortega 11,110,333 5.00%
Montserrat Andrade Detrell MD, PhD 10,254,841 4.62%
Safoles SA 8,615,205 3.88%
Norges Bank Investment Management 6,383,289 2.87%
Kutxabank SA 4,671,000 2.10%
José Luis Fernández Puentes, PhD 3,209,426 1.44%
Santiago Alfredo Fernández Puentes 3,074,810 1.38%
JPMorgan Asset Management (UK) Ltd. 3,016,224 1.36%
Dimensional Fund Advisors LP 1,532,551 0.69%
Holdings
NameShares%Valuation
Zeltia SA (ZEL) 1,326,2510.60%4,480,633 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
PHARMACYCLICS, IN..
INCYTE CORPORATIO..
ALKERMES PLC
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
UNITED THERAPEUTI..
ISIS PHARMACEUTIC..
PUMA BIOTECHNOLOG..
-
CELLTRION, INC.
QIAGEN NV
SEATTLE GENETICS,..
ICON PLC
INTREXON CORP
CHARLES RIVER LAB..
PAREXEL INTERNATI..
BIO-TECHNE CORP
SYNAGEVA BIOPHARM..
BB BIOTECH AG
-
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
Sector Biotechnology & Medical Research
Zeltia SA : Connections
Bankinter Foundation of Innovation
High Tech Hotels & Resorts SA
Fundación de Ayuda contra la Drogadicción
Museo Nacional Centro De Arte Reina Sofia
Fundacion Arquitectura Y Sociedad
Spanish Association of Bioenterprises
Near Technologies Madrid SL
Asociación Madrileña de la Empresa Familiar
Asociación de Editores de Diarios Españoles
Alianza por la Investigación e Innovación en la Salud
Diario El Correo SA
Círculo de Empresarios Vascos
CZ Veterinaria SA
Grupo Corporativo ONO SA
Everis Spain SL
Fundacion Menela
Euroamérica Foundation
Solchaga Recio Asociados SA
Vitro Cristalglass SL
Centro de Estudios e Investigaciones Tecnicas de Gipuzkoa
Real Instituto Elcano
Corporación Patricio Echeverria SA
Diana Capital SGECR SA
Universidad Complutense de Madrid
Sociedad Vascongada de Publicaciones SA
Perez Orive & Associates
Eduardo Serra y Asociados SL
Deusto Business School
everis Foundation
European Publishers Council
Company contact information
Zeltia SA
Plaza Descubridor Diego de Ordás, 3
Planta 5
Madrid 28003

Phone : +34.91.444.45.00
Fax : +34.91.593.29.94
Web : www.zeltia.es
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF